Clinical outcomes associated with SARS-CoV-2 Omicron (B.1.1.529) variant and BA.1/BA.1.1 or BA.2 subvariant infection in Southern California.

Lewnard, Joseph A; Hong, Vennis X; Patel, Manish M; Kahn, Rebecca; Lipsitch, Marc; Tartof, Sara Y

Lewnard, Joseph A; Hong, Vennis X; Patel, Manish M; Kahn, Rebecca; Lipsitch, Marc; Tartof, Sara Y.

Afiliação

Lewnard JA; Division of Epidemiology, School of Public Health, University of California, Berkeley, Berkeley, CA, USA. jLewnard@berkeley.edu.
Hong VX; Division of Infectious Diseases & Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA, USA. jLewnard@berkeley.edu.
Patel MM; Center for Computational Biology, College of Engineering, University of California, Berkeley, Berkeley, CA, USA. jLewnard@berkeley.edu.
Kahn R; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA.
Lipsitch M; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Tartof SY; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Nat Med ; 28(9): 1933-1943, 2022 09.

Article em En | MEDLINE | ID: mdl-35675841

Assuntos

COVID-19; SARS-CoV-2; COVID-19/epidemiologia; California/epidemiologia; Humanos; Saúde Pública; SARS-CoV-2/genética

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Risk_factors_studies País/Região como assunto: America do norte Idioma: En Revista: Nat Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google